pharmacokinetics of glp-1 receptor agonists Lixisenatide, a Agonist, Determined by a Novel Liquid Chromatography–Tandem Mass Spectrometry Analysis in Rats Current Insights, Advantages and Challenges

Microdosing allows for: Lower overall medication exposure

Learn how low-dose semaglutide and tirzepatide may support metabolism, menopause, inflammation, and autoimmune health.

GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs

Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.

For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity

Highlights from the American Diabetes Association on type 2 diabetes care